Three-dimensional bioprinting

Three-dimensional bioprinting has been studied in 10 papers since 2024: none in people yet, 1 in cells, 9 reviews; 9 in the past year. No study of it in people or animals has been published yet. The newest paper, Nov 2, 2026: “3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function”.

Intervention

10 papers study it1 findingUpdated

2 new papers in 30 daysSee all 10 papers on three-dimensional bioprinting

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Cells1

What did studies of three-dimensional bioprinting find?

1

Studies of three-dimensional bioprinting measured one outcome, cell viability.

Cell viability

upin reviews1

1 study
  1. Three-dimensional bioprinting improves cell viability (composite bioinks (alginate and gelatin)) (>= 99%).

    “composite bioinks, such as alginate and gelatin, maintained high cell viability greater than or equal to 99%”

    Reviewcomposite bioinks (alginate and gelatin)

    Tissue engineering

    Transdigital

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 2Jul 2026: 3Aug 2026: 2Sep 2026: 0Oct 2026: 0Nov 2026: 19 papers in 12 months